• Explore /
  • Poster
  • / Clinical validation of Northstar Response, a novel methylated ctDNA therapy response monitoring assay in patients with advanced GI cancer undergoing active treatment.

Clinical validation of Northstar Response, a novel methylated ctDNA therapy response monitoring assay in patients with advanced GI cancer undergoing active treatment.

Abstract Poster

Authors

null

Ilyas Sahin

University of Florida/UF Health Cancer Center, Gainesville, FL

Ilyas Sahin , Doga Kahramangil , Sherise C. Rogers , Brian Hemendra Ramnaraign , Pravalika Manda , Matthew Gordon Varga , Gary A. Palmer , Patrick Peiyong Ye , Thomas J. George

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2024 ASCO Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session A: Cancers of the Esophagus and Stomach and Other Gastrointestinal Cancers

Track

Esophageal and Gastric Cancer,Other GI Cancer

Sub Track

Tumor Biology, Biomarkers, and Pathology

Citation

J Clin Oncol 42, 2024 (suppl 3; abstr 756)

DOI

10.1200/JCO.2024.42.3_suppl.756

Abstract #

756

Poster Bd #

M11

Abstract Disclosures

Similar Posters

First Author: Vincent T. Ma

First Author: Bruna Pellini

First Author: Albert Jang

First Author: Xinrong Yang